+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Dietary Supplements Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4602409
  • Report
  • April 2019
  • Region: Global
  • 154 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Glanbia PLC
  • Gnc Holdings Inc.
  • Merck Kgaa
  • Natures Bounty
  • MORE
Market Overview

The dietary supplements market (henceforth, referred to as market studied) was valued at USD 101.38 billion in 2018, registering a CAGR of 6.9%, during the forecast period (2019-2024). The dietary supplements market is preliminarily driven by the paradigm shift toward preventive health management practices, amid rising healthcare costs and increasing burden of lifestyle diseases. Digitization in retail is expected to boost the future growth of dietary supplements. Moreover, the popularity of herbal supplements is also expected to drive the market growth in the future. Based on product type, the vitamin segment is steadily growing, whereas the fatty acid segment represents the fastest growing supplement segment due to the popularity of omega-3-based supplements. In the end user segment, the infant and children sub-segments are the fastest growing end-user segments as companies have increased their supplement portfolio based on the high demand for infant formulae. Asia-Pacific is the fastest growing region in the dietary supplements market, driven by major investment opportunities especially for herbal and Ayurveda extract-based products.

Scope of the Report

Dietary supplements are majorly consumed with a prime intention to enhance the intake of essential nutritional components in the human body. Dietary supplements market covers the knowledge of aggressive analysis, geographical regions, and manufacturers of dietary supplement.

Key Market Trends

Rising Healthcare Cost and Focus on Preventive Health Management

The global marketplace has witnessed a paradigm shift from curative practices to preventive management in healthcare, making it a prime growth factor for the market studied. Healthcare as an industry contributes extensively to the overall economy. Emphasis on care management, focus on paying for value, and rising general inflation are major factors influencing the healthcare cost. Population in the United States, Europe, and Japan is aging, prompting consumers to seek a variety of dietary supplements for maintaining and enhancing the overall health and well being. The healthcare cost is substantially high in emerging economies due to higher per-capita out-of-pocket spending on healthcare, amid the burden of communicable and non-communicable diseases. Such trends have prompted consumers to opt for dietary supplements. The growing importance of health as a lifestyle choice has attracted many companies to enter into the vitamin, mineral, and botanical segments of the market studied. Thus, the intense focus on the preventive healthcare system, coupled with robust endorsements and marketing efforts of lifestyle enhancement products, is driving the market studied.

Asia- Pacific Dominate the Global Market

The Asia - Pacific dietary supplements market has witnessed rapid growth in both developed and developing countries. Demand for supplements in countries like India, China, and Japan has increased in recent years, owing to the considerable presence of the aging population in such developing countries. Supplements are most in demand, owing to their various health benefits. The dietary supplements market in the region is anticipated to offer major investment opportunities, especially for herbal and Ayurveda extract-based products. This is because of the ample availability of raw materials in India and Southeast Asian countries.

Competitive Landscape

The dietary supplements market faces high competition, which is held by the leading players, including Pfizer, Sanofi, Herbalife, Glanbia Nutritionals, Abbott, Bayer AG, GlaxoSmithKline, Reckitt Benckiser, and Merck. The supplements market has a wide scope, considering the existing companies. With prevalent FDA regulations, the leading players have an upper edge and continue to dominate the market. Also, the major global players have the geographical reach and also high brand awareness among consumers, which gives them an upper hand. The North American dietary supplement market is fragmented and consequently, witnesses high competition. Herbalife, Amway, and Farmacias Similares SA de CV are the leading players.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Glanbia PLC
  • Gnc Holdings Inc.
  • Merck Kgaa
  • Natures Bounty
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter Five Forces Framework
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition

5 MARKET SEGMENTATION
5.1 Type
5.1.1 Vitamin
5.1.2 Mineral
5.1.3 Botanical
5.1.4 Enzyme
5.1.5 Fatty Acid
5.1.6 Protein
5.1.7 Other types
5.2 End User
5.2.1 Adult
5.2.2 Infant
5.2.3 Children
5.2.4 Pregnant Women
5.2.5 Elderly
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Russia
5.3.2.5 Italy
5.3.2.6 Spain
5.3.2.7 Rest of Europe
5.3.3 Asia - Pacific
5.3.3.1 China
5.3.3.2 India
5.3.3.3 Rest of Asia - Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East & Africa
5.3.5.1 South Africa
5.3.5.2 United Arab Emirates
5.3.5.3 Rest of Middle East & Africa

6 Competitive Landscape
6.1 Most Adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 Pfizer Inc.
6.3.2 Amway
6.3.3 Suntory Holdings Ltd
6.3.4 Glanbia PLC
6.3.5 Glaxosmithkline PLC
6.3.6 Abbott
6.3.7 Herbalife Limited
6.3.8 Reckitt Benckiser Group PLC
6.3.9 Bayer AG
6.3.10 Blackmores Limited
6.3.11 Otsuka Holdings Co. Ltd
6.3.12 Gnc Holdings Inc.
6.3.13 Sanofi
6.3.14 Merck Kgaa
6.3.15 Natures Bounty
6.3.16 Miki Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Pfizer Inc.
  • Amway
  • Suntory Holdings Ltd
  • Glanbia PLC
  • Glaxosmithkline PLC
  • Abbott
  • Herbalife Limited
  • Reckitt Benckiser Group PLC
  • Bayer AG
  • Blackmores Limited
  • Otsuka Holdings Co. Ltd
  • Gnc Holdings Inc.
  • Sanofi
  • Merck Kgaa
  • Natures Bounty
  • Miki Corporation
Note: Product cover images may vary from those shown
Adroll
adroll